Sierra Legacy Group Reduces Stock Position in UnitedHealth Group Incorporated $UNH

Sierra Legacy Group lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 12.1% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,974 shares of the healthcare conglomerate’s stock after selling 410 shares during the quarter. Sierra Legacy Group’s holdings in UnitedHealth Group were worth $928,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Caitlin John LLC raised its holdings in shares of UnitedHealth Group by 14.8% during the first quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock worth $451,000 after purchasing an additional 111 shares during the period. Murphy Pohlad Asset Management LLC raised its stake in UnitedHealth Group by 21.8% during the second quarter. Murphy Pohlad Asset Management LLC now owns 4,425 shares of the healthcare conglomerate’s stock worth $1,380,000 after acquiring an additional 791 shares during the period. Triumph Capital Management bought a new position in shares of UnitedHealth Group during the second quarter valued at approximately $1,324,000. Wealth Effects LLC lifted its holdings in shares of UnitedHealth Group by 14.4% in the 2nd quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate’s stock worth $1,463,000 after purchasing an additional 591 shares during the last quarter. Finally, Towercrest Capital Management bought a new position in UnitedHealth Group during the 2nd quarter worth $236,000. Institutional investors own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

UNH has been the subject of several analyst reports. Leerink Partners set a $410.00 price target on shares of UnitedHealth Group and gave the company an “outperform” rating in a report on Wednesday, October 29th. Zacks Research upgraded shares of UnitedHealth Group from a “strong sell” rating to a “hold” rating in a research report on Monday, October 6th. Sanford C. Bernstein boosted their price objective on UnitedHealth Group from $433.00 to $440.00 and gave the stock an “outperform” rating in a research report on Thursday, October 30th. Wells Fargo & Company lifted their target price on UnitedHealth Group from $267.00 to $400.00 and gave the company an “overweight” rating in a research note on Tuesday, October 7th. Finally, JPMorgan Chase & Co. raised their price target on UnitedHealth Group from $310.00 to $425.00 and gave the company an “overweight” rating in a report on Thursday, October 9th. Eighteen analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $397.12.

UnitedHealth Group Stock Down 2.1%

Shares of UNH stock opened at $313.77 on Wednesday. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.82. The stock has a market cap of $284.22 billion, a PE ratio of 16.38, a price-to-earnings-growth ratio of 2.28 and a beta of 0.47. The business’s fifty day moving average is $346.96 and its 200-day moving average is $317.63. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $622.83.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The firm had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. During the same period in the previous year, the company earned $7.15 earnings per share. UnitedHealth Group’s revenue was up 12.2% compared to the same quarter last year. Equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 16th. Investors of record on Monday, December 8th will be issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date is Monday, December 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 46.14%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.